Vonicog alfa
Vonvendi, Veyvondi (vonicog alfa) is a protein pharmaceutical. Vonicog alfa was first approved as Vonvendi on 2018-08-31. It has been approved in Europe to treat von willebrand diseases.
| Trade Name | Veyvondi |
|---|---|
| Common Name | Vonicog alfa |
| Indication | von willebrand diseases |
| Drug Class | Hemostatic |
